1998
DOI: 10.1021/bi9728405
|View full text |Cite
|
Sign up to set email alerts
|

Differential Intracellular Signaling of the GalR1 and GalR2 Galanin Receptor Subtypes

Abstract: The diverse physiological functions exerted by the neuropeptide galanin may be regulated by multiple G protein-coupled receptor subtypes and intracellular signaling pathways. Three galanin receptor subtypes (GalRs) have been recently cloned, but the G protein coupling profiles of these receptors are not completely understood. We have generated GalR1- and GalR2-expressing Chinese hamster ovary (CHO) cell lines and systematically examined the potential for these two receptors to couple to the Gs, Gi, Go, and Gq … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

16
209
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 237 publications
(225 citation statements)
references
References 40 publications
16
209
0
Order By: Relevance
“…This effect is likely to be mediated by GalR2 [10], the only GalR that signals through a stimulatory Gq/11 pathway, thus its activation by galanin could result in smooth muscle contraction [6]. Participation of GalR2 in the effect of galanin on gastric motility is supported by our findings of high levels of GalR2 mRNA in the stomach and is consistent with functional studies indicating the GalR2 as the main GalR implicated in the excitatory mechanism for smooth muscle contraction [27]. Indeed, galanin induces contraction of the jejunum and colon by direct effect on longitudinal smooth muscle [1,26].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…This effect is likely to be mediated by GalR2 [10], the only GalR that signals through a stimulatory Gq/11 pathway, thus its activation by galanin could result in smooth muscle contraction [6]. Participation of GalR2 in the effect of galanin on gastric motility is supported by our findings of high levels of GalR2 mRNA in the stomach and is consistent with functional studies indicating the GalR2 as the main GalR implicated in the excitatory mechanism for smooth muscle contraction [27]. Indeed, galanin induces contraction of the jejunum and colon by direct effect on longitudinal smooth muscle [1,26].…”
Section: Discussionsupporting
confidence: 90%
“…Galanin receptor activation involves different signaling pathways. GalR1 and GalR3 activate intracellular effectors through pertussis-toxin sensitive Gi/o proteins [27] resulting in inhibition of adenylyl cyclase activity and activation of inward K + current [23]. By contrast, GalR2 predominantly couples positively to phospholipase C through a Gq/11 protein to mediate inositol phospholipid turnover and Ca 2+ mobilization with a pertussis-toxin independent mechanism, even though it also signals through Gi/Go proteins [22,27].…”
Section: Introductionmentioning
confidence: 99%
“…Among these receptors, GalR1 and GalR3 mainly activate G i/o types of G proteins mediating inhibitory actions of galanin (Habert-Ortoli et al, 1994;Burgevin et al, 1995;Parker et al, 1995;see Branchek et al, 2000). In contrast, the GalR2 subtype can transmit either stimulatory effects of galanin, for example, on neurotransmitter release, acting via G q/11 types of G proteins (Smith et al, 1997;Wang et al, 1997;Fathi et al, 1998), or it can inhibit neurotransmission via G i/o types (Fathi et al, 1998;Wang et al, 1998;see Branchek et al, 2000). Thus, the physiological effects of galanin are varied and complex.…”
Section: Introductionmentioning
confidence: 99%
“…Both GalR1 and GalR3 signal via G i-protein and decrease cyclic AMP levels by inhibiting adenylate cyclase (Smith et al, 1997). On the other hand, the main pathway downstream from GalR2 is through coupling to G q/11-protein and activates phospholipase C (PLC) to increase inositol triphosphate accumulation and the increase of intracellular Ca 2+ (Wang et al, 1998;Lundstrom et al, 2005); this would presumably stimulate neuronal activity and neurotransmitter release. In this study, AR-M1896 (GalR2 agonist) did not modulate IBa in NTS.…”
Section: Discussionmentioning
confidence: 99%